5 completed, 1 unknown. 6 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 6 | Completed 5, Unknown 1 |
Follow Heroin Dependence: new trials by email Literature Review of Heroin Dependence trials Research Report on Heroin Dependence
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Extended-Release Naltrexone Opioid Treatment at Jail Re-Entry Extended-Release Naltrexone - Heroin Dependence, Opioid-Related Disorders | Phase 4 | Completed | NYU Langone Health | 217 | 2014-06-27 | 2021-06-25 |
| Depot Naltrexone Mechanism of Action in Heroin Dependent Patients Using fMRI and SPECT Naltrexone - Opioid-Related Disorders, Heroin Dependence | Phase 4 | Completed | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 40 | 2013-01-01 | 2014-10-13 |
| Biomarkers of Injectable Extended Release Naltrexone Treatment Naltrexone - Heroin Dependence, Opioid Dependence | Phase 4 | Completed | University of Pennsylvania | 32 | 2011-10-01 | 2023-01-12 |
| Transfer From Methadone to Buprenorphine Maintenance Treatment Using Buprenorphine Patches Buprenorphine patch and sublingual tablets - Heroin Addiction | Phase 4 | Unknown | Psychiatric University Hospital, Zurich | 10 | 2008-08-01 | 2008-09-10 |
| A Stepwise Strategy Utilizing Buprenorphine and Methadone methadone, buprenorphine / methadone sequence, Relapse prevention - Heroin Dependence | Phase 4 | Completed | Karolinska University Hospital | 96 | 2005-08-01 | 2006-10-24 |
| Effects of Buspirone in Opiate Withdrawal Buspirone - Heroin Dependence | Phase 4 | Completed | National Institute on Drug Abuse (NIDA) | 2002-01-01 | 2017-01-12 |
Opioid-Related Disorders (3) · Behavior, Addictive (1)
Chemically-Induced Disorders (6) · Mental Disorders (6) · Narcotic-Related Disorders (6) · Substance-Related Disorders (6) · Opioid-Related Disorders (3) · Behavior (1) · Compulsive Behavior (1) · Impulsive Behavior (1)
vivitrol (3) · Buprenorphine (2) · Naltrexone (2) · Administration, Sublingual (1) · Buspirone (1) · Methadone (1) · Secondary Prevention (1)
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · Karolinska University Hospital (1) · NYU Langone Health (1) · National Institute on Drug Abuse (NIDA) (1) · Psychiatric University Hospital, Zurich (1) · University of Pennsylvania (1)
United States (3) · Netherlands (1) · Sweden (1) · Switzerland (1)
Daniel Langleben, MD (1) · Joshua D Lee, MD MS (1) · Laure Buydens-Branchey, M.D. (1) · Lukas Boesch, PhD (1) · Markus Heilig, MD PhD (1) · Rudolf Stohler, MD (1) · Wim van den Brink, MD PhD (1)
PMID 15876901, PMID 27178765, PMID 31570100, PMID 32379516, PMID 40342086
U01DA033336 (1)